ReviewWiener klinische Wochenschrift2024

Optimal use of granulocyte colony-stimulating factor prophylaxis to improve survival in cancer patients receiving treatment : An expert view.

Pere Gascón et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.